Variability in the leptin receptor gene and other risk factors for post-transplant diabetes mellitus in renal transplant recipients

References

• Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention. Acta Diabetol. 2018;55:763–779.
   PubMed Web of Science ®Google Scholar
• Pham PT, Pham PM, Pham SV, et al. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011;4:175–186.
   PubMedGoogle Scholar
• Zelle DM, Corpeleijn E, Deinum J, et al. Pancreatic beta-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 2013;36:1926–1932.
   PubMed Web of Science ®Google Scholar
• Israni AK, Snyder JJ, Skeans MA, et al. Predicting coronary heart disease after kidney transplantation: patient outcomes in renal transplantation (PORT) study. Am J Transplant. 2010;10:338–353.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3:178–185.
   PubMed Web of Science ®Google Scholar
• Bonato V, Cataldo D, Dotta F, et al. Diagnosis and approach to post-transplant diabetes. Curr Diab Rep. 2009;9:317–323.
   PubMed Web of Science ®Google Scholar
• Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev. 2016;37:37–61.
   PubMed Web of Science ®Google Scholar
• Mora PF. New-onset diabetes after renal transplantation. J Investig Med. 2010;58:755–763.
   PubMed Web of Science ®Google Scholar
• Yates CJ, Fourlanos S, Hjelmesaeth J, et al. New-onset diabetes after kidney transplantation-changes and challenges. Am J Transplant. 2012;12:820–828.
   PubMed Web of Science ®Google Scholar
• Luan FL, Steffick DE, Ojo AO. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation. 2011;91:334–341.
   PubMed Web of Science ®Google Scholar
• Kang ES, Kim MS, Kim YS, et al. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Diabetes Care. 2008;31:63–68.
   PubMed Web of Science ®Google Scholar
• Sarno G, Muscogiuri G, De Rosa P. New-onset diabetes after kidney transplantation: prevalence, risk factors, and management. Transplantation. 2012;93:1189–1195.
   PubMed Web of Science ®Google Scholar
• Gervasini G, Luna E, Garcia-Cerrada M, et al. Risk factors for post-transplant diabetes mellitus in renal transplant: role of genetic variability in the CYP450-mediated arachidonic acid metabolism. Mol Cell Endocrinol. 2016;419:158–164.
   PubMed Web of Science ®Google Scholar
• Morton GJ, Schwartz MW. Leptin and the central nervous system control of glucose metabolism. Physiol Rev. 2011;91:389–411.
   PubMed Web of Science ®Google Scholar
• Meek TH, Morton GJ. The role of leptin in diabetes: metabolic effects. Diabetologia. 2016;59:928–932.
   PubMed Web of Science ®Google Scholar
• Lian Y, Tang Z, Xie Y, et al. Leptin receptor gene polymorphisms and risk of hypertension: a meta-analysis. Int J Clin Exp Med. 2015;8:14277–14282.
   PubMed Web of Science ®Google Scholar
• Aijala M, Santaniemi M, Bloigu R, et al. Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death. Gene. 2014;534:88–92.
   PubMed Web of Science ®Google Scholar
• Li YY, Wang H, Yang XX, et al. LEPR gene Gln223Arg polymorphism and type 2 diabetes mellitus: a meta-analysis of 3367 subjects. Oncotarget. 2017;8:61927–61934.
   PubMedGoogle Scholar
• Wu L, Sun D. Leptin receptor gene polymorphism and the risk of cardiovascular disease: a systemic review and meta-analysis. Int J Environ Res Public Health. 2017;14:pii: E375.
   Web of Science ®Google Scholar
• Chavarria-Avila E, Vazquez-Del Mercado M, Gomez-Banuelos E, et al. The impact of LEP G-2548A and LEPR Gln223Arg polymorphisms on adiposity, leptin, and leptin-receptor serum levels in a Mexican mestizo population. Biomed Res Int. 2015;2015:539408.
   PubMedGoogle Scholar
• Suriyaprom K, Tungtrongchitr R, Thawnasom K. Measurement of the levels of leptin, BDNF associated with polymorphisms LEP G2548A, LEPR Gln223Arg and BDNF Val66Met in Thai with metabolic syndrome. Diabetol Metab Syndr. 2014;6:6.
   PubMed Web of Science ®Google Scholar
• de Luis DA, Aller R, Izaola O, et al. Influence of Lys656Asn polymorphism of leptin receptor gene on leptin response secondary to two hypocaloric diets: a randomized clinical trial. Ann Nutr Metab. 2008;52:209–214.
   PubMed Web of Science ®Google Scholar
• Davidson JA, Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist’s view. Diabetes Care. 2004;27:805–812.
   PubMed Web of Science ®Google Scholar
• Joosten SA, Sijpkens YW, van Kooten C, et al. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int. 2005;68:1–13.
   PubMed Web of Science ®Google Scholar
• Gervasini G, Garcia M, Macias RM, et al. CYP2C8*3 polymorphism and donor age are associated with allograft dysfunction in kidney transplant recipients treated with calcineurin inhibitors. J Clin Pharmacol. 2013;53:427–434.
   PubMed Web of Science ®Google Scholar
• Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet. 2004;364:1814–1827.
   PubMed Web of Science ®Google Scholar
• Levey AS, Greene T, Kuske J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.
   Google Scholar
• Chung WK, Power-Kehoe L, Chua M, et al. Exonic and intronic sequence variation in the human leptin receptor gene (LEPR). Diabetes. 1997;46:1509–1511.
   PubMed Web of Science ®Google Scholar
• Stratigopoulos G, LeDuc CA, Matsuoka N, et al. Functional consequences of the human leptin receptor (LEPR) Q223R transversion. Obesity (Silver Spring). 2009;17:126–135.
   PubMed Web of Science ®Google Scholar
• Sun Q, Cornelis MC, Kraft P, et al. Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels. Hum Mol Genet. 2010;19:1846–1855.
   PubMed Web of Science ®Google Scholar
• Gonzalez JR, Armengol L, Sole X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23:644–645.
   PubMed Web of Science ®Google Scholar
• Gervasini G, Garcia-Cerrada M, Vergara E, et al. Polymorphisms in CYP-mediated arachidonic acid routes affect the outcome of renal transplantation. Eur J Clin Invest. 2015;45:1060–1068.
   PubMed Web of Science ®Google Scholar
• McCaughan JA, McKnight AJ, Maxwell AP. Genetics of new-onset diabetes after transplantation. J Am Soc Nephrol. 2014;25:1037–1049.
   PubMed Web of Science ®Google Scholar
• Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metab Clin Exp. 1976;25:1567–1574.
   PubMed Web of Science ®Google Scholar
• Wyse BM, Dulin WE. The influence of age and dietary conditions on diabetes in the db mouse. Diabetologia. 1970;6:268–273.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345–1350.
   PubMed Web of Science ®Google Scholar
• Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540–543.
   PubMed Web of Science ®Google Scholar
• Dedinska I, Mackova N, Kantarova D, et al. Leptin – a new marker for development of post-transplant diabetes mellitus? J Diabetes Complications. 2018;32:863–869.
   PubMed Web of Science ®Google Scholar
• Jackson KG, Delgado-Lista J, Gill R, et al. The leptin receptor Gln223Arg polymorphism (rs1137101) mediates the postprandial lipaemic response, but only in males. Atherosclerosis. 2012;225:135–141.
   PubMed Web of Science ®Google Scholar
• Abdu Allah AM, El-Hefnway SM, Alhanafy AM, et al. Leptin receptor gene (A/G) polymorphism rs1137101 and renal cell carcinoma. Mol Cell Biochem. 2018;448:137–144.
   PubMed Web of Science ®Google Scholar
• Mackey-Lawrence NM, Guo X, Sturdevant DE, et al. Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with entamoeba histolytica. Infect Immun. 2013;81:1460–1470.
   PubMed Web of Science ®Google Scholar
• Madan R, Guo X, Naylor C, et al. Role of leptin-mediated colonic inflammation in defense against clostridium difficile colitis. Infect Immun. 2014;82:341–349.
   PubMed Web of Science ®Google Scholar
• Yang MM, Wang J, Fan JJ, et al. Variations in the obesity gene “LEPR” contribute to risk of type 2 diabetes mellitus: evidence from a meta-analysis. J Diabetes Res. 2016;2016:5412084.
   PubMedGoogle Scholar
• Yang Y, Niu T. A meta-analysis of associations of LEPR Q223R and K109R polymorphisms with type 2 diabetes risk. PLoS One. 2018;13:e0189366.
   PubMed Web of Science ®Google Scholar
• Murugesan D, Arunachalam T, Ramamurthy V, et al. Association of polymorphisms in leptin receptor gene with obesity and type 2 diabetes in the local population of Coimbatore. Indian J Hum Genet. 2010;16:72–77.
   Google Scholar
• Yiannakouris N, Yannakoulia M, Melistas L, et al. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab. 2001;86:4434–4439.
   PubMed Web of Science ®Google Scholar
• Verkerke H, Naylor C, Zabeau L, et al. Kinetics of leptin binding to the Q223R leptin receptor. PLoS One. 2014;9:e94843.
   PubMed Web of Science ®Google Scholar
• Banks AS, Davis SM, Bates SH, et al. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem. 2000;275:14563–14572.
   PubMed Web of Science ®Google Scholar
• Pan W, Allison MB, Sabatini P, et al. Transcriptional and physiological roles for STAT proteins in leptin action. Mol Metab. 2019;22:121–131.
   PubMedGoogle Scholar
• Havel PJ, Uriu-Hare JY, Liu T, et al. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol. 1998;274:R1482–1491.
   PubMedGoogle Scholar
• Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes. 1999;48:1487–1492.
   PubMed Web of Science ®Google Scholar
• Yu X, Park BH, Wang MY, et al. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci USA. 2008;105:14070–14075.
   PubMed Web of Science ®Google Scholar
• Nicoletto BB, Souza GC, Goncalves LF, et al. Leptin, insulin resistance, and metabolic changes 5 years after renal transplantation. J Ren Nutr. 2012;22:440–449.
   PubMed Web of Science ®Google Scholar
• Romanowski M, Dziedziejko V, Maciejewska-Karlowska A, et al. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus. Pharmacogenomics. 2015;16:1243–1251.
   PubMed Web of Science ®Google Scholar
• Gaynor JJ, Ciancio G, Guerra G, et al. Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients. Clin Transplant. 2015;29:301–310.
   PubMed Web of Science ®Google Scholar
• Marrero D, Hernandez D, Tamajon LP, et al. Pre-transplant weight but not weight gain is associated with new-onset diabetes after transplantation: a multi-centre cohort Spanish study. NDT Plus. 2010;3:ii15–ii20.
   PubMedGoogle Scholar
• Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005;67:2415–2421.
   PubMed Web of Science ®Google Scholar
• Numakura K, Satoh S, Tsuchiya N, et al. Clinical and genetic risk factors for post-transplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation. 2005;80:1419–1424.
   PubMed Web of Science ®Google Scholar
• Cole EH, Prasad GV, Cardella CJ, et al. A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients. Transplant Res. 2013;2:1.
   PubMedGoogle Scholar
• Courivaud C, Ladriere M, Toupance O, et al. Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation. Clin Transplant. 2011;25:794–799.
   PubMed Web of Science ®Google Scholar
• Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant. 2003;3:590–598.
   PubMed Web of Science ®Google Scholar
• Vincenti F, Schena FP, Paraskevas S, et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant. 2008;8:307–316.
   PubMed Web of Science ®Google Scholar
• Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331:810.
   PubMed Web of Science ®Google Scholar